Pentalong

Pentalong is a German pharmaceutical company specialized in the cardiovascular therapeutic area, specifically known for its flagship product of the same name. The company's primary offering, Pentalong (pentaerithrityl tetranitrate or PETN), is a long-acting nitrate vasodilator used for the prophylaxis of angina pectoris and the treatment of chronic heart failure. PETN is distinguished from other nitrates by its unique pharmacological profile, which includes a reduced risk of nitrate tolerance and the absence of oxidative stress induction in the vasculature. Historically based in Wandlitz, Germany, the company was a key player in the clinical and regulatory development of PETN in Europe. Following its acquisition and subsequent corporate restructuring, the company's operations and the Pentalong brand were integrated into PUREN Pharma, a member of the STADA Group. Pentalong remains a significant brand in the German market for long-term cardiovascular management.